StockStory.org on MSN

Life sciences tools & services stocks Q4 earnings: Illumina (NASDAQ:ILMN) firing on all cylinders

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
BioSpace

DNA Microarray Market Size to Grow approximately USD 6.13 Bn by 2034

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
ahajournals.org

Prognostic Value of a Multi-mRNA Signature for 1-Year All-Cause Death in Hospitalized Patients With Heart Failure With a Preserved Ejection Fraction

Heart failure with preserved ejection fraction is a major global public health problem, while effective risk stratification tools are still lacking. We sought to construct a multi-mRNA signature to ...
Business Wire

Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification ...
Associated Press

Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...
IEEE

A Cross-Platform Comparison of Affymetrix, Agilent, and Illumina Microarray Reveals Functional Genomics in Colorectal Cancer Progression

Abstract: Colorectal cancer is one of the most common cancers with the second highest mortality rate in the world. The microarray can be used to collect gene expression alteration information from ...